Allegro Diagnostics to Participate in Upcoming Conferences in September  
8/30/2012 10:08:04 AM

MAYNARD, Mass.--(BUSINESS WIRE)--Allegro Diagnostics today announced its participation in two upcoming conferences. Allegro Diagnostics is developing a molecular testing platform utilizing gene expression of normal epithelial cells in the respiratory tract to detect early signs of lung cancer.